Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 4105 - 4112 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCN1846 | Antibiotic BU 2313A |
|
1. Antibiotic Bu-2313 A and Antibiotic Bu-2313 B each exhibit a broad antibiotic
spectrum against Gram-positive and Gram-negative anaerobic bacteria, and show in vivo activity against experimental infections produced by B. fragilis and C. perfringens. |
|
| BCN1848 | Oleficin |
|
1. Oleficin, a polyene antibiotic, it is active against Grampositive bacteria and has no effect upon the growth of fungi and yeasts.
2. Oleficin has effects on mitochondrial functions can be explained on the basis of an increase of the inner membrane permeability as the consequence of the depletion of Mg2+ from mitochondria caused by the antibiotic. 3. Oleficin could as an ionophore of Mg2+ in isolated rat liver mitochondria, preferentially inhibit growth of the yeast Saccharomyces cerevisiae on non-fermentable substrates. |
|
| BCN1849 | Oteromycin |
|
1. Oteromycin is a inhibitor of HIV-1 integrase.
|
|
| BCN1850 | Antibiotic ZG 1494alpha |
|
1. Antibiotic ZG 1494alpha is a novel inhibitor of platelet-activating factor (PAF) acetyltransferase.
2. Antibiotic ZG-1494alpha exhibits antifungal activity against Candida albicans. |
|
| BCN1853 | Pramanicin |
|
1. Pramanicin, an antifungal agent, has vasorelaxant effect, it induces a slow endothelium-dependent relaxation, which could be reversed with the NO synthase inhibitor, L-NOARG .
2. Pramanicin has potent, selective, and irreversible inhibitory effect on the endothelial , thus it has potential development into an anti-angiogenic drug. 3. Pramanicin causes an initial slow endothelium-dependent, NO-mediated vascular relaxation, followed by a cytotoxic effect on vascular endothelial cells, eventually resulting in the loss of vasorelaxant function. 4. Pramanicin as a potential apoptosis-inducing small molecule, which acts through a well-defined JNK- and p38-dependent apoptosis signalling pathway in Jurkat T leukemia cells. 5. Pramanicin is an antimicrobial agent . |
|
| BCN1855 | Reutericyclin |
|
1. Reutericyclin is a unique antimicrobial tetramic acid produced by some strains of Lactobacillus reuteri.
2. Reutericyclin and nisin exhibit divergent effects on heat- and pressure-induced spore inactivation and membrane fluidity. 3. Dissipation of the membrane potential by active Reutericyclins correlated with inhibition of macromolecular synthesis in cells. 4. All reutericyclins can inhibit the growth of clinical isolates of drug-resistant Staphylococcus aureus, which exemplify the prospect of developing reutericyclins as new topical antibiotics. |
|
| BCN1856 | Rubroside G |
|
1. Rubroside G may show antifungal activity against Aspergillus fumigatus and Candida albicans.
|
|
| BCN1857 | Rubroside H |
|
1. Rubroside H may show antifungal activity against Aspergillus fumigatus and Candida albicans.
|
|